Analysts' mean price target for Monopar Therapeutics (MNPR) implies 88.9% upside, indicating a bullish consensus on the stock's valuation. The article also notes strong agreement among analysts in raising earnings estimates, which supports a positive fundamental outlook despite the limited historical effectiveness of price targets.
Analysts' mean price target for Monopar Therapeutics (MNPR) implies 88.9% upside, indicating a bullish consensus on the stock's valuation. The article also notes strong agreement among analysts in raising earnings estimates, which supports a positive fundamental outlook despite the limited historical effectiveness of price targets.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
